Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death.
Identifieur interne : 000373 ( Main/Exploration ); précédent : 000372; suivant : 000374Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death.
Auteurs : Meiju Aij L [Finlande] ; Merja Santaniemi ; Risto Bloigu ; Y Antero Kes Niemi ; Olavi UkkolaSource :
- Gene ; 2014.
English descriptors
- KwdEn :
- Adult, Arginine (genetics), Cardiovascular Diseases (epidemiology), Cardiovascular Diseases (genetics), Cardiovascular Diseases (mortality), Coronary Disease (epidemiology), Coronary Disease (genetics), Female, Genotype, Homozygote, Humans, Incidence, Male, Middle Aged, Receptors, Leptin (genetics), Risk Factors.
- MESH :
- chemical , genetics : Arginine, Receptors, Leptin.
- epidemiology : Cardiovascular Diseases, Coronary Disease.
- genetics : Cardiovascular Diseases, Coronary Disease.
- mortality : Cardiovascular Diseases.
- Adult, Female, Genotype, Homozygote, Humans, Incidence, Male, Middle Aged, Risk Factors.
Abstract
Two leptin receptor single nucleotide polymorphisms, Lys109Arg and Gln223Arg, have been shown to associate with several risk factors for cardiovascular disease. In addition, we have previously shown that Arg109 and Arg223 homozygotes displayed lower intima-media thickness in our well-defined OPERA (Oulu Project Elucidating Risk of Atherosclerosis) study. This current research investigated the impact of these LEPR polymorphisms on cardiovascular events and related death as well as to total mortality in the 19-year follow-up of OPERA. Subjects were randomly selected, middle-aged drug-treated hypertensives and their age- and sex-matched control subjects recruited to the OPERA study between 1990 and 1993. Mortality and hospital events of 1045 subjects were followed up until 2009. A total of 151 coronary heart disease (CHD) and 211 cardiovascular disease (CVD) events or deaths including 58 CHD and 69 CVD deaths occurred. Furthermore, during this follow-up, a total of 165 subjects died. Logistic regression analysis was performed to assess the impact of Lys109Arg and Gln223Arg on the events and death. Further modeling was performed with Cox regression for Lys109Arg. The logistic regression analysis revealed a significant protective impact of Arg109Arg genotype on CHD (OR 0.433; CI 95% 0.217-0.863) and CVD (OR 0.540; CI 95% 0.309-0.942) events or death as well as on total mortality (OR 0.390; CI 95% 0.196-0.775) when adjusted with age, sex and study group. Even after further adjustment with BMI, smoking status, systolic blood pressure and low-density lipoprotein cholesterol, the protective effect of Arg109Arg on CHD events or death and total mortality still remained statistically significant (OR 0.463; CI 95% 0.230-0.931 and OR 0.442; CI 95% 0.218-0.896, respectively). Arg109Arg was also shown to confer protection against CHD mortality (HR 0.224; CI95% 0.055-0.919) and overall mortality (HR 0.413; CI95% 0.218-0.783) also in Cox regression analysis. In conclusion, the Arg109Arg genotype of LEPR seems to be protective from cardiovascular events and death and this phenomenon seems to be independent of the traditional risk factors for atherosclerosis.
DOI: 10.1016/j.gene.2013.10.003
PubMed: 24140454
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000201
- to stream PubMed, to step Curation: 000201
- to stream PubMed, to step Checkpoint: 000160
- to stream Ncbi, to step Merge: 000B28
- to stream Ncbi, to step Curation: 000B28
- to stream Ncbi, to step Checkpoint: 000B28
- to stream Main, to step Merge: 000362
- to stream Main, to step Curation: 000373
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death.</title>
<author><name sortKey="Aij L, Meiju" sort="Aij L, Meiju" uniqKey="Aij L M" first="Meiju" last="Aij L">Meiju Aij L</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Clinical Medicine, Department of Internal Medicine and Biocenter Oulu, University of Oulu and Clinical Research Center, Oulu University Hospital, Oulu, Finland. Electronic address: meiju.aijala@oulu.fi.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Institute of Clinical Medicine, Department of Internal Medicine and Biocenter Oulu, University of Oulu and Clinical Research Center, Oulu University Hospital, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Santaniemi, Merja" sort="Santaniemi, Merja" uniqKey="Santaniemi M" first="Merja" last="Santaniemi">Merja Santaniemi</name>
</author>
<author><name sortKey="Bloigu, Risto" sort="Bloigu, Risto" uniqKey="Bloigu R" first="Risto" last="Bloigu">Risto Bloigu</name>
</author>
<author><name sortKey="Kes Niemi, Y Antero" sort="Kes Niemi, Y Antero" uniqKey="Kes Niemi Y" first="Y Antero" last="Kes Niemi">Y Antero Kes Niemi</name>
</author>
<author><name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24140454</idno>
<idno type="pmid">24140454</idno>
<idno type="doi">10.1016/j.gene.2013.10.003</idno>
<idno type="wicri:Area/PubMed/Corpus">000201</idno>
<idno type="wicri:Area/PubMed/Curation">000201</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000160</idno>
<idno type="wicri:Area/Ncbi/Merge">000B28</idno>
<idno type="wicri:Area/Ncbi/Curation">000B28</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B28</idno>
<idno type="wicri:Area/Main/Merge">000362</idno>
<idno type="wicri:Area/Main/Curation">000373</idno>
<idno type="wicri:Area/Main/Exploration">000373</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death.</title>
<author><name sortKey="Aij L, Meiju" sort="Aij L, Meiju" uniqKey="Aij L M" first="Meiju" last="Aij L">Meiju Aij L</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Clinical Medicine, Department of Internal Medicine and Biocenter Oulu, University of Oulu and Clinical Research Center, Oulu University Hospital, Oulu, Finland. Electronic address: meiju.aijala@oulu.fi.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Institute of Clinical Medicine, Department of Internal Medicine and Biocenter Oulu, University of Oulu and Clinical Research Center, Oulu University Hospital, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Santaniemi, Merja" sort="Santaniemi, Merja" uniqKey="Santaniemi M" first="Merja" last="Santaniemi">Merja Santaniemi</name>
</author>
<author><name sortKey="Bloigu, Risto" sort="Bloigu, Risto" uniqKey="Bloigu R" first="Risto" last="Bloigu">Risto Bloigu</name>
</author>
<author><name sortKey="Kes Niemi, Y Antero" sort="Kes Niemi, Y Antero" uniqKey="Kes Niemi Y" first="Y Antero" last="Kes Niemi">Y Antero Kes Niemi</name>
</author>
<author><name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
</author>
</analytic>
<series><title level="j">Gene</title>
<idno type="e-ISSN">1879-0038</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Arginine (genetics)</term>
<term>Cardiovascular Diseases (epidemiology)</term>
<term>Cardiovascular Diseases (genetics)</term>
<term>Cardiovascular Diseases (mortality)</term>
<term>Coronary Disease (epidemiology)</term>
<term>Coronary Disease (genetics)</term>
<term>Female</term>
<term>Genotype</term>
<term>Homozygote</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Receptors, Leptin (genetics)</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Arginine</term>
<term>Receptors, Leptin</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cardiovascular Diseases</term>
<term>Coronary Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Cardiovascular Diseases</term>
<term>Coronary Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Cardiovascular Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Genotype</term>
<term>Homozygote</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Risk Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Two leptin receptor single nucleotide polymorphisms, Lys109Arg and Gln223Arg, have been shown to associate with several risk factors for cardiovascular disease. In addition, we have previously shown that Arg109 and Arg223 homozygotes displayed lower intima-media thickness in our well-defined OPERA (Oulu Project Elucidating Risk of Atherosclerosis) study. This current research investigated the impact of these LEPR polymorphisms on cardiovascular events and related death as well as to total mortality in the 19-year follow-up of OPERA. Subjects were randomly selected, middle-aged drug-treated hypertensives and their age- and sex-matched control subjects recruited to the OPERA study between 1990 and 1993. Mortality and hospital events of 1045 subjects were followed up until 2009. A total of 151 coronary heart disease (CHD) and 211 cardiovascular disease (CVD) events or deaths including 58 CHD and 69 CVD deaths occurred. Furthermore, during this follow-up, a total of 165 subjects died. Logistic regression analysis was performed to assess the impact of Lys109Arg and Gln223Arg on the events and death. Further modeling was performed with Cox regression for Lys109Arg. The logistic regression analysis revealed a significant protective impact of Arg109Arg genotype on CHD (OR 0.433; CI 95% 0.217-0.863) and CVD (OR 0.540; CI 95% 0.309-0.942) events or death as well as on total mortality (OR 0.390; CI 95% 0.196-0.775) when adjusted with age, sex and study group. Even after further adjustment with BMI, smoking status, systolic blood pressure and low-density lipoprotein cholesterol, the protective effect of Arg109Arg on CHD events or death and total mortality still remained statistically significant (OR 0.463; CI 95% 0.230-0.931 and OR 0.442; CI 95% 0.218-0.896, respectively). Arg109Arg was also shown to confer protection against CHD mortality (HR 0.224; CI95% 0.055-0.919) and overall mortality (HR 0.413; CI95% 0.218-0.783) also in Cox regression analysis. In conclusion, the Arg109Arg genotype of LEPR seems to be protective from cardiovascular events and death and this phenomenon seems to be independent of the traditional risk factors for atherosclerosis.</div>
</front>
</TEI>
<affiliations><list><country><li>Finlande</li>
</country>
</list>
<tree><noCountry><name sortKey="Bloigu, Risto" sort="Bloigu, Risto" uniqKey="Bloigu R" first="Risto" last="Bloigu">Risto Bloigu</name>
<name sortKey="Kes Niemi, Y Antero" sort="Kes Niemi, Y Antero" uniqKey="Kes Niemi Y" first="Y Antero" last="Kes Niemi">Y Antero Kes Niemi</name>
<name sortKey="Santaniemi, Merja" sort="Santaniemi, Merja" uniqKey="Santaniemi M" first="Merja" last="Santaniemi">Merja Santaniemi</name>
<name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
</noCountry>
<country name="Finlande"><noRegion><name sortKey="Aij L, Meiju" sort="Aij L, Meiju" uniqKey="Aij L M" first="Meiju" last="Aij L">Meiju Aij L</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000373 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000373 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Musique |area= OperaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:24140454 |texte= Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24140454" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a OperaV1
![]() | This area was generated with Dilib version V0.6.21. | ![]() |